Business Description
Cue Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US22978P1066
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.16 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.43 | |||||
Debt-to-EBITDA | -0.29 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -8.38 | |||||
Beneish M-Score | 9.81 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.9 | |||||
3-Year EBITDA Growth Rate | 13.8 | |||||
3-Year EPS without NRI Growth Rate | 10.8 | |||||
3-Year FCF Growth Rate | 8.9 | |||||
3-Year Book Growth Rate | -32.9 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 92.84 | |||||
9-Day RSI | 74.54 | |||||
14-Day RSI | 60.54 | |||||
6-1 Month Momentum % | -25.57 | |||||
12-1 Month Momentum % | -61.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.47 | |||||
Quick Ratio | 2.47 | |||||
Cash Ratio | 2.27 | |||||
Days Sales Outstanding | 63.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.9 | |||||
Shareholder Yield % | -16.07 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -730.47 | |||||
Net Margin % | -711.84 | |||||
FCF Margin % | -554.05 | |||||
ROE % | -118.52 | |||||
ROA % | -73.66 | |||||
ROIC % | -237.61 | |||||
ROC (Joel Greenblatt) % | -603.17 | |||||
ROCE % | -94.86 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 11 | |||||
PB Ratio | 2.67 | |||||
Price-to-Tangible-Book | 3.22 | |||||
EV-to-EBIT | -0.97 | |||||
EV-to-EBITDA | -1.04 | |||||
EV-to-Revenue | 6.73 | |||||
EV-to-Forward-Revenue | 2.74 | |||||
EV-to-FCF | -1.34 | |||||
Price-to-Net-Current-Asset-Value | 4.65 | |||||
Price-to-Net-Cash | 5.64 | |||||
Earnings Yield (Greenblatt) % | -103.28 | |||||
FCF Yield % | -51.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cue Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 6.494 | ||
EPS (TTM) (€) | -0.989 | ||
Beta | 1.36 | ||
Volatility % | 53.37 | ||
14-Day RSI | 60.54 | ||
14-Day ATR (€) | 0.052092 | ||
20-Day SMA (€) | 1.3725 | ||
12-1 Month Momentum % | -61.28 | ||
52-Week Range (€) | 1.25 - 4.114 | ||
Shares Outstanding (Mil) | 48.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cue Biopharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cue Biopharma Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cue Biopharma Inc Frequently Asked Questions
What is Cue Biopharma Inc(FRA:1UC)'s stock price today?
When is next earnings date of Cue Biopharma Inc(FRA:1UC)?
Does Cue Biopharma Inc(FRA:1UC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |